Microsoft is teaming up with a $5 billion Seattle

Microsoft is teaming up with a $5 billion Seattle biotech to unravel the mystery of how the immune system responds to the coronavirus, and it could lead to new treatments and tests

Business Insider

Published 13 May 2020

· The range of symptoms and disease severity from the novel coronavirus remains largely a mystery to doctors and researchers.
· Microsoft is working with the Seattle-based biotech Adaptive Biotechnologies to better understand the different ways that individuals' immune systems respond to the virus.
· The duo are now...

Full Article

Microsoft is teaming up with a $5 billion Seattle biotech to unravel the mystery of how the immune system responds to the coronavirus, and it could lead to new treatments and tests

Microsoft is teaming up with a $5 billion Seattle biotech to unravel the mystery of how the immune system responds to the coronavirus, and it could lead to new treatments and tests

You might like

Related news coverage

The untold story of Moderna as the biotech's coronavirus vaccine faces a test that could make it one of the most consequential startups of all time (MRNA)

Immunai launches out of stealth with $20 million in funding, as biotech remains a bright spot in an otherwise turbulent startup ecosystem

Microsoft and a Seattle biotech are seeking 1,000 volunteers to give blood for a virtual coronavirus study. Here's how you can enroll and make up to $250.

Investors just poured $14.6 billion into startups working to transform healthcare. These are the 10 companies that pulled in the most cash.

More Thoughts On Wealth And Tax Alternatives – OpEd

Advertisement